Functional dichotomy in natural killer cell signaling: Vav1-dependent and -independent mechanisms

Journal of Experimental Medicine

Volumn 193, Issue 12, 2001, Pages 1413-1424

  Colucci, Francesco ^a   Rosmaraki, Eleftheria ^a   Bregenholt, Søren ^a   Samson, Sandrine I ^a   Di Bartolo, Vincenzo ^a   Turner, Martin ^b   Vanes, Lesley ^c   Tybulewicz, Victor ^c   Di Santo, James P ^a  

^a INSTITUT PASTEUR   (France)

^b BABRAHAM INSTITUTE   (United Kingdom)

^c NATIONAL INSTITUTE FOR MEDICAL RESEARCH   (United Kingdom)

Author keywords

Cytokines; Exocytosis; Listeria infection; Lymphoid development; Tumor clearance

Indexed keywords

GAMMA INTERFERON;

ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CYTOTOXICITY; LISTERIA MONOCYTOGENES; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

ANIMALS; ANTIBODY-DEPENDENT CELL CYTOTOXICITY; CALCIUM; CELL CYCLE PROTEINS; CELL DIFFERENTIATION; CELLS, CULTURED; CYTOTOXICITY, IMMUNOLOGIC; EXOCYTOSIS; INTERFERON TYPE II; KILLER CELLS, NATURAL; LISTERIA INFECTIONS; MICE; MICE, KNOCKOUT; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MITOGEN-ACTIVATED PROTEIN KINASES; NEOPLASMS, EXPERIMENTAL; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-VAV; RECEPTORS, IMMUNOLOGIC; SIGNAL TRANSDUCTION; T-LYMPHOCYTES;

EID: 0035908099     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.193.12.1413     Document Type: Article

References (57)

1. Views on Vav
2. Vav, a novel human oncogene derived from a locus ubiquitously expressed in hematopoietic cells
3. Product of vav proto-oncogene defines a new class of tyrosine protein kinase substrates
4. Tyrosine phosphorylation of vav proto-oncogene product containing SH2 domain and transcription factor motifs
5. Defective antigen receptor-mediated proliferation of B and T cells in the absence of Vav
6. The hematopoietically expressed vav proto-oncogene shares homology with the dbl GDP-GTP exchange factor, the bcr gene and a yeast gene (CDC24) involved in cytoskeletal organization
7. Proto-vav and gene expression
8. Rac-1 dependent stimulation of the JNK/SAPK signaling pathway by Vav
9. Faciogenital dysplasia protein (FGD1) and Vav, two related proteins required for normal embryonic development, are upstream regulators of Rho GTPases
10. Phosphotyrosine-dependent activation of Rac-1 GDP/GTP exchange by the vav proto-oncogene product
11. Lymphocyte signalling: A coordinating role for Vav?
12. Defective T-cell receptor signalling and positive selection of Vav-deficient CD4+ CD8+ thymocytes
13. Defective signalling through the T- and B-cell antigen receptors in lymphoid cells lacking the vav proto-oncogene
14. A requirement for the Rho-family GTP exchange factor Vav in positive and negative selection of thymocytes
15. Vav is a regulator of cytoskeletal reorganization mediated by the T-cell receptor
16. Defects in actin-cap formation in Vav-deficient mice implicate an actin requirement for lymphocyte signal transduction
17. Vav regulates peptide-specific apoptosis in thymocytes
18. Natural killer cell differentiation: Insights from knockout and transgenic mouse models and in vitro systems
19. Mice lacking flt3 ligand have deficient hematopoiesis affecting hematopoietic progenitor cells, dendritic cells, and natural killer cells
20. The receptor tyrosine c-kit provides a critical signal for survival, expansion, and maturation of mouse natural killer cells
21. Reversible defects in natural killer and memory CD8 T cell lineages in interleukin 15-deficient mice
22. Inhibition of gamma delta T cell development and early thymocyte maturation in IL-7 -/- mice
23. Steel factor stimulates the tyrosine phosphorylation of the proto-oncogene product, p95vav, in human hemopoietic cells
24. Mitogenic signalling and substrate specificity of the Flk2/Flt3 receptor tyrosine kinase in fibroblasts and interleukin 3-dependent hematopoietic cells
25. Biology of natural killer cells
26. The Rho-family GTP exchange factor Vav is a critical transducer of T cell receptor signals to the calcium, ERK, and NF-kappaB pathways
27. Role of substrates and products of PI 3-kinase in regulating activation of Rac-related guanosine triphosphatases by Vav
28. CD19 as a membrane-anchored adaptor protein of B lymphocytes: Costimulation of lipid and protein kinases by recruitment of Vav
29. Fc receptor stimulation of phosphatidylinositol 3-kinase in natural killer cells is associated with protein kinase C-independent granule release and cell-mediated cytotoxicity
30. Phospholipase Cgamma2 is essential in the functions of B cell and several Fc receptors
31. Vav in natural killer cells is tyrosine phosphorylated upon cross-linking of Fc gamma RIIIA and is constitutively associated with a serine/threonine kinase
32. The Vav-Rac1 pathway in cytotoxic lymphocytes regulates the generation of cell-mediated killing
33. Interferon alpha induces rapid tyrosine phosphorylation of the vav proto-oncogene product in hematopoietic cells
34. Dependence of both spontaneous and antibody-dependent, granule exocytosis-mediated NK cell cytotoxicity on extracellular signal-regulated kinases
35. CD16 cross-linking induces both secretory and extracellular signal-regulated kinase (ERK)-dependent cytosolic phospholipase A2 (PLA2) activity in human natural killer cells: Involvement of ERK, but not PLA2, in CD16-triggered granule exocytosis
36. Control of lyric function by mitogen-activated protein kinase/extracellular regulatory kinase 2 (ERK2) in a human natural killer cell line: Identification of perforin and granzyme B mobilization by functional ERK2
37. Differential role of p38 and c-Jun N-terminal kinase 1 mitogen-activated protein kinases in NK cell cytotoxicity
38. Role for the Rac1 exchange factor Vav in the signaling pathways leading to NK cell cytotoxicity
39. Dissecting NK cell development using a novel alymphoid mouse model: Investigating the role of the c-abl proto-oncogene in murine NK cell differentiation
40. RAG-2-deficient mice lack mature lymphocytes owing to inability to initiate V(D)J rearrangement
41. Alteration of the natural killer repertoire in H-2 transgenic mice: Specificity of rapid lymphoma cell clearance determined by the H-2 phenotype of the target
42. The ClpP serine protease is essential for the intracellular parasitism and virulence of Listeria monocytogenes
43. Redundant role of the syk protein tyrosine kinase in mouse NK cell differentiation
44. NK cell granule exocytosis and cytokine production inhibited by Ly-49A engagement
45. Acquisition of Ly49 receptor expression by developing natural killer cells
46. Selective rejection of H-2-deficient lymphoma variants suggests alternative immune defence strategy
47. Differential tumor surveillance by natural killer (NK) and NKT cells
48. Natural killer cells in antiviral defense: Function and regulation by innate cytokines
49. Regulation of gamma interferon production by natural killer cells in scid mice: Roles of tumor necrosis factor and bacterial stimuli
50. Identification of the homologous beige and Chediak-Higashi syndrome genes
51. Deficient peptide loading and MHC class II endosomal sorting in a human genetic immunodeficiency disease: The Chediak-Higashi syndrome
52. How do cytotoxic lymphocytes kill their targets?
53. The rho family guanine nucleotide exchange factor vav-2 regulates the development of cell-mediated cytotoxicity
54. The oncogene product Vav is a crucial regulator of primary cytotoxic T cell responses but has no apparent role in CD28-mediated co-stimulation
55. NK cell receptors
56. Natural cytotoxicity receptors that trigger human NK-cell-mediated cytolysis
57. Signal transduction during natural killer cell activation: Inside the mind of a killer